Doxazosin Tablet
Product Images NDC 0904-5523

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 0904-5523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

Chemical structure diagram of Doxazosin mesylate, showing the molecular arrangement of the active ingredient Doxazosin with a mesylate group.*

FDA Label Image

Table3.jpg (Table3)

Data table summarizing symptom score and maximum flow rate changes from placebo-controlled trials of Doxazosin. It includes three studies with various dosages, showing mean baseline and mean change values for symptom scores and flow rates, alongside a bar graph illustrating maximum flow rate improvements in Study 2. Statistical significance indicators are noted.*

FDA Label Image

Figure1.jpg (Figure1)

Two line graphs comparing Doxazosin and placebo over 14 weeks of treatment. The left graph shows mean change in total symptom score from baseline, with Doxazosin showing greater symptom reduction than placebo. The right graph depicts mean increase in maximum urinary flow rate from baseline, with Doxazosin showing a higher increase compared to placebo. Both graphs note statistical significance with markers.*

FDA Label Image

1mg Carton Label (B2cb1c04 F7a7 4887 B41c 9e4f11f33bdf 02)

Doxazosin 1 mg tablets, USP, oral tablet unit dose packaging by Major Pharmaceuticals. The label displays NDC 0904-5522-61, contains 100 tablets (10x10), and indicates prescription use only. Instructions include dispensing with patient information and storage temperature guidelines. The product is packaged and distributed by Major Pharmaceuticals, Indianapolis, IN.*

FDA Label Image

2mg Carton Label (B2cb1c04 F7a7 4887 B41c 9e4f11f33bdf 01)

Doxazosin Tablets USP 2 mg unit dose packaging label from Major Pharmaceuticals. The label states the count of 100 tablets (10 x 10) and indicates prescription only status. It includes storage instructions, a warning about child safety, and notes the drug is packaged and distributed by Major Pharmaceuticals, Indianapolis. The label has purple highlighting for the strength and a barcode at the bottom.*

FDA Label Image

4mg Carton Label (B2cb1c04 F7a7 4887 B41c 9e4f11f33bdf 00)

Label for Doxazosin Tablets, USP 4 mg by Major Pharmaceuticals, presented in unit dose packaging. The label states 100 tablets per package (10 x 10) and includes storage instructions, dosage note, and warnings. It specifies that each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin. The label includes NDC 0904-5524-61 and indicates the product is Rx only, packaged and distributed by Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.